Skip to main content
. 2022 May 10;6(1):e001460. doi: 10.1136/bmjpo-2022-001460

Table 3.

Summary of case reports of dexmedetomidine in newborn infants

Reference
setting
Case description outcomes
Notes
Finkel 2007
USA31
2 days old, 3 kg female
Repair of bladder exstrophy
Received dexmedetomidine infusion
Hypothermia and bradycardia—at 0.4 μg/kg/hour dose reduced and maintained on 0.2 μg/kg/hour without further adverse events
O’Mara 2009
USA16
24 weeks GA, 9 days old infant on high frequency oscillatory ventilation. Was on fentanyl and lorazepam
Started at 0.5 μg/kg over 10 min followed by 0.25 μg/kg/hour increased by 0.05–0.1 μg/kg/hour every 12 hours if needed. Max rate of 0.7 μg/kg/hour for 19 days.
Calmed and remained sedated
Allowed weaning of ventilation and extubation
Kubota 2012
Japan44
Term infant—ventilated EEG confirmed seizures, stopped 12 hours after discontinuation of dexmedetomidine infusion without any antiepileptic medication
Normal development

EEG, electroencephalogram; GA, gestational age; HIE, hypoxic ischaemic encephalopathy; NICHD, Eunice Kennedy Shriver National Institute of Child Health and Human Development.